Abstract
Plasma apolipoproteins have been long considered as stable and invariable structures, characterized by the presence of long linear stretches and, particularly, by amphipathic helical segments. Although some apoprotein polymorphism was earlier suggested, based on the detection of apo E variations in type III hyperlipoproteinemia, the possibility that significant changes in the apolipoprotein structure might be associated with phenotypic abnormalities, seemed remote.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.L. Jackson, J.D. Morrisset and A.M. Gotto, Lipoprotein structure and metabolism, Physiol. Rev., 56: 259 (1976).
G. Utermann, M. Jaeschke and J. Menzel, Familial hyperlipoproteinemia type III: deficiency of a specific apolipo-protein (apo E III) in the very low density lipoproteins, FEBS Lett., 56: 352 (1975).
G.J. Miller and N.E. Miller, Plasma high density lipoprotein concentration and development of ischaemic heart disease, Lancet, i: 16 (1975).
C.R. Sirtori, G. Franceschini, G. Gianfranceschi, M. Sirtori, G. Montanari, E. Bosisio, E. Mantero and A. Bondioli, Metformin improves peripheral vascular flow inonhyperlipidemic patients with arterial disease, J. Cardiovasc. Pharmacol., 6: 914 (1984).
V. Blaton, F. Soeteway, D. Vandanne, B. Declercq and H. Peeters, Effect of polyunsaturated phosphatidylcholine on human types II and IV hyperlipoproteinemias, Artery, 2: 309 (1976).
G. Franceschini, C.R. Sirtori, A Capurso, K.H. Weisgraber and R.W. Mahley, AI-Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modification and without clinical atherosclerosis in an Italian family, J. Clin. Invest., 66: 892 (1980).
K.H. Weisgraber, T.P. Bersot, R.W. Mahley, G. Franceschini and C.R. Sirtori, AI-Milano apoprotein. Isolation and characterization of a cysteine-containing variant of the AI apoprotein from human high density lipoproteins, J. Clin. Invest., 66: 901 (1980).
K.H. Weisgraber, S.C. Rall jr., T. P. Bersot, R. W. Mahley, G. Franceschini and C. R. Sirtori, Apolipoprotein AI-Milano. Detection of normal AI in affected subjects and evidence for a cysteine for arginine substitution in the variant AI, J. Biol. Chem., 257: 9926 (1983).
V. Gualandri, G.B. Orsini, L. Stangoni and E. Porta, Familiarità della pressione arteriosa. Studio in una popolazione chiusa, Min. Cardioangiol., 31: 1 (1983).
G.R. Warnick, J. Benderson and J.J. Albers, Dextran sulfate precipitation procedure for quantitation of high density lipoprotein, Clin. Chem., 28: 1379 (1982).
V. Gualandri, G. Franceschini, C.R. Sirtori, G. Gianfranceschi, G. B. Orsini, A. Cerrone and A. Menotti, AI-Milano apoprotein. Identification of the complete kindred and evidence of a dominant genetic transmission, Am. J. Human Gen., (1985), in press.
G. Franceschini, M. Sirtori, G. Gianfranceschi and C.R. Sirtori, Relation between the HDL apoproteins and AI isoprotein in subjects with the AI-Milano abnormality, Metabolism, 30: 502 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sirtori, C.R., Franceschini, G., Gualandri, V., Cerrone, A., Fedrici, D. (1986). AI Milano — History and Clinical Profile. In: Sirtori, C.R., Nichols, A.V., Franceschini, G. (eds) Human Apolipoprotein Mutants. NATO ASI Series, vol 112. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9474-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9474-1_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9476-5
Online ISBN: 978-1-4615-9474-1
eBook Packages: Springer Book Archive